deoxypyridinoline has been researched along with osteoprotegerin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (75.00) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delmas, PD; Heufelder, AE; Hofbauer, LC; Roth, S; Szulc, P | 1 |
| Aringer, M; Bernecker, PM; Ebner, W; Grampp, S; Grisar, J; Kainberger, F; Pietschmann, P; Redlich, K; Sedlak, M; Smolen, JS; Spitzauer, S; Wolozcszuk, W | 1 |
| Dal Fiume, C; Gatti, E; Lanzi, R; Losa, M; Rubinacci, A; Sirtori, M; Villa, I | 1 |
| Adamo, EB; Altavilla, D; Bartolone, S; Bitto, A; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Inferrera, MA; Marini, H; Marini, R; Romeo, A; Squadrito, F; Squadrito, G | 1 |
| Atteritano, M; Cincotta, M; Frisina, N; Gaudio, A; Guarino, R; La Rosa, M; Lasco, A; Meo, A; Morabito, N; Pizzoleo, MA | 1 |
| Baek, KH; Choi, MG; Kang, MI; Kim, SW; Lee, WY; Oh, ES; Oh, KW; Park, SW; Rhee, EJ; Yoo, HJ | 1 |
| Quarles, LD; Spurney, RF; Wang, L | 1 |
| Boissier, MC; Cohen-Solal, ME; Corrado, A; deVernejoul, MC; Lemeiter, D; Saidenberg-Kermanac'h, N | 1 |
| Ichinose, Y; Inoue, M; Mochizuki, S; Seino, Y; Tanaka, H; Tsuda, E | 1 |
| Cao, XZ; Fang, TY; Liao, EY; Liu, SP; Luo, XH; Wu, XP; Xie, H; Zhang, H | 1 |
| Ishida, H; Kikuyama, M; Kurose, T; Maruyama, M; Nagamatsu, S; Seino, Y; Sugimoto, C; Suzuki, K; Takizawa, M; Ushikawa, K | 1 |
| Atteritano, M; Catalano, A; Fries, W; Frisina, N; Gaudio, A; Lasco, A; Morabito, N; Trifiletti, A; Vergara, C | 1 |
| Barreto, DV; Barreto, FC; Canziani, ME; Carvalho, AB; Draibe, SA; Jorgetti, V; Moyses, RM; Neves, CL | 1 |
| Asaba, Y; Harada, A; Hiramatsu, K; Ikeda, K; Ito, M; Katagiri, N; Kobayashi, T; Matsui, Y; Niida, S; Nimura, Y; Takewaka, T | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; San Millán, JL | 1 |
| Gengenbacher, M; Hofstetter, W; Sebald, HJ; Seitz, M; Villiger, PM | 1 |
| Suzuki, Y | 1 |
| Menuki, K; Nakai, K; Nakamura, T; Sakai, A; Taketa, T; Tanaka, K; Tanaka, S; Yamane, H | 1 |
| Akira, N; Hayato, K; Masaaki, T; Tetsuyuki, N; Yasunori, K | 1 |
| Han, X; Li, N; Li, Y; Pei, X; Wang, J; Xu, Y; Yang, R | 1 |
| Abadia, AC; Casado-Caballero, FJ; González-Calvin, JL; Martin-Ibañez, JJ; Mundi, JL | 1 |
| Baek, KH; Kang, MI; Kim, SW; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ; Yun, EJ | 1 |
| Bachmann, H; Broecker-Preuss, M; Hilken, G; Kauther, MD; von Knoch, M; Wedemeyer, C; Zimmermann, C | 1 |
| Garcia, P; Histing, T; Holstein, JH; Klein, M; Kuntz, S; Menger, MD; Pohlemann, T; Scheuer, C; Stenger, D; Tami, A | 1 |
| Gulseren, A; Peyman, B; Pinar, A | 1 |
| Chen, C; Liang, MK; Liao, EY; Peng, YQ; Wu, XP; Wu, XY; Zhang, H | 1 |
| Jung, JU; Mei, L; Pan, JX; Shen, C; Wu, H; Xia, WF; Xiong, L; Xiong, WC | 1 |
| Arslan, MS; Cakal, E; Caliskan, M; Demirci, T; Karakose, M; Ozbek, M; Ozdemir, S; Sahin, M; Topaloglu, O; Tutal, E; Ucan, B | 1 |
1 review(s) available for deoxypyridinoline and osteoprotegerin
| Article | Year |
|---|---|
[Clinical significance of biomarkers in diagnosis of metabolic bone diseases].
Topics: Acid Phosphatase; Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Bone Resorption; Collagen Type I; Humans; Isoenzymes; Osteocalcin; Osteogenesis; Osteoporosis; Osteoprotegerin; Peptide Fragments; Peptides; Procollagen; RANK Ligand; Tartrate-Resistant Acid Phosphatase | 2007 |
2 trial(s) available for deoxypyridinoline and osteoprotegerin
| Article | Year |
|---|---|
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women.
Topics: Amino Acids; Bone Density; Bone Remodeling; Bone Resorption; Carrier Proteins; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Genistein; Glycoproteins; Humans; Membrane Glycoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoprotegerin; Placebos; Postmenopause; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2004 |
Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin.
Topics: Aged; Amino Acids; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen Type I; Etidronic Acid; Female; Humans; Middle Aged; Osteocalcin; Osteoprotegerin; Postmenopause; Risedronic Acid; Vitamin D | 2011 |
25 other study(ies) available for deoxypyridinoline and osteoprotegerin
| Article | Year |
|---|---|
Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amino Acids; Bone Density; Bone Remodeling; Calcifediol; Estradiol; Glycoproteins; Humans; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Testosterone | 2001 |
Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Amino Acids; Arthritis, Psoriatic; Arthritis, Reactive; Biomarkers; Bone Density; Bone Resorption; Cohort Studies; Female; Glycoproteins; Humans; Male; Middle Aged; Osteocalcin; Osteoprotegerin; Probability; Prognosis; Prohibitins; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2002 |
GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults.
Topics: Adolescent; Adult; Amino Acids; Calcium; Female; Glycoproteins; Growth Hormone; Human Growth Hormone; Humans; Male; Middle Aged; Osteocalcin; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2003 |
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.
Topics: Adult; Amino Acids; beta-Thalassemia; Biomarkers; Bone Density; Bone Resorption; Carrier Proteins; Case-Control Studies; Estradiol; Female; Femur; Glycoproteins; Hemoglobins; Humans; Lumbar Vertebrae; Male; Membrane Glycoproteins; Osteoporosis; Osteoprotegerin; Radiography; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Regression Analysis; Testosterone | 2004 |
The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women.
Topics: Adult; Age Factors; Aged; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Enzyme-Linked Immunosorbent Assay; Female; Femur Neck; Follicle Stimulating Hormone; Humans; Lumbar Vertebrae; Middle Aged; Minerals; Osteoprotegerin; Postmenopause; Receptors, Tumor Necrosis Factor | 2004 |
Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
Topics: Aging; Amino Acids; Animals; beta-Adrenergic Receptor Kinases; Biomarkers; Bone and Bones; Bone Density; Carrier Proteins; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Glycoproteins; Membrane Glycoproteins; Mice; Mice, Transgenic; Osteoblasts; Osteoclasts; Osteoprotegerin; Parathyroid Hormone; Peptide Fragments; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Parathyroid Hormone; Receptors, Tumor Necrosis Factor; RNA, Messenger | 2004 |
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Topics: Amino Acids; Animals; Antibodies; Arthritis, Experimental; Bone Density; Bone Resorption; Femur; Glycoproteins; Inflammation; Male; Mice; Mice, Inbred DBA; Osteogenesis; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2004 |
Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading.
Topics: Amino Acids; Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Elasticity; Femur; Glycoproteins; Hindlimb Suspension; Male; Osteoclasts; Osteoprotegerin; Phosphorus; Radiography; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Stress, Mechanical; Tibia; Weight-Bearing | 2004 |
[Serum osteoprotegrin and serum bone gamma-carboxyglutamine acid-containing protein are correlated with bone mineral density in normal women].
Topics: 1-Carboxyglutamic Acid; Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone and Bones; Bone Density; Female; Humans; Middle Aged; Osteoblasts; Osteocalcin; Osteoprotegerin; Postmenopause; Receptors, Tumor Necrosis Factor | 2004 |
Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Topics: Acid Phosphatase; Amino Acids; Biomarkers; Bone Density; C-Peptide; Calcitriol; Calcium; Collagen; Collagen Type I; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Glycoproteins; Humans; Insulin; Isoenzymes; Magnesium; Male; Middle Aged; Osteocalcin; Osteoclasts; Osteoprotegerin; Parathyroid Hormone; Peptides; Phosphorus; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sex Factors; Tartrate-Resistant Acid Phosphatase | 2005 |
Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Amino Acids; Bone Density; Bone Diseases, Metabolic; Carrier Proteins; Chronic Disease; Estradiol; Glycoproteins; Humans; Insulin-Like Growth Factor I; Liver Diseases; Male; Membrane Glycoproteins; Middle Aged; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sex Hormone-Binding Globulin; Testosterone; Vitamin D | 2005 |
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Bone Remodeling; Calcium; Carrier Proteins; Case-Control Studies; Cross-Sectional Studies; Female; Glycoproteins; Humans; Male; Membrane Glycoproteins; Middle Aged; Osteoporosis; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Prevalence; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Renal Dialysis; Vitamin D; White People | 2006 |
Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
Topics: Aged; Aged, 80 and over; Alendronate; Amino Acids; Animals; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Collagen Type I; Female; gamma-Glutamyltransferase; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Osteoporosis, Postmenopausal; Osteoprotegerin; Peptides | 2006 |
Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women.
Topics: Adult; Amino Acids; Cohort Studies; Creatinine; Female; Humans; Hypothyroidism; Osteocalcin; Osteoprotegerin; Postmenopause; Prospective Studies; Thyroid Neoplasms; Thyrotropin; Thyroxine; Triiodothyronine | 2007 |
Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
Topics: Adult; Aged; Amino Acids; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Bone Resorption; Case-Control Studies; Cells, Cultured; Female; Humans; Infliximab; Male; Middle Aged; Osteocalcin; Osteoclasts; Osteoprotegerin; RANK Ligand; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2008 |
Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells.
Topics: Amino Acids; Animals; Arthritis, Experimental; Biomarkers; Body Weight; Bone and Bones; Bone Marrow Cells; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation; Interleukin-6; Male; Mice; Organ Size; Osteocalcin; Osteoprotegerin; RANK Ligand; RNA, Messenger; Synovial Membrane; Tibia | 2008 |
Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis.
Topics: Alkaline Phosphatase; Amino Acids; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Collagen Type I; Etanercept; Female; Humans; Immunoglobulin G; Male; Middle Aged; Osteoprotegerin; Peptides; RANK Ligand; Receptors, Tumor Necrosis Factor | 2008 |
Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Body Weight; Bone and Bones; Bone Density; Collagen Type I; Estradiol; Female; Femur; Gelatin; Gene Expression; Interleukin-1beta; Interleukin-6; Organ Size; Osteocalcin; Osteoprotegerin; Ovariectomy; Polymerase Chain Reaction; RANK Ligand; Rats; Rats, Sprague-Dawley; Tibia; Tumor Necrosis Factor-alpha; Uterus | 2009 |
Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Amino Acids; Bone and Bones; Bone Density; Cross-Sectional Studies; Estradiol; Female; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Middle Aged; Osteoprotegerin; Postmenopause; Receptor Activator of Nuclear Factor-kappa B; Receptors, Tumor Necrosis Factor; Risk Factors; Tumor Necrosis Factors | 2009 |
The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women.
Topics: Amino Acids; Aorta; Asian People; Bone Density; Bone Resorption; Calcinosis; Calcium; Female; Femur Neck; Humans; Korea; Middle Aged; Osteoprotegerin; Polymorphism, Genetic; RANK Ligand | 2010 |
Biochemical markers of particle induced osteolysis in C57BL/6 mice.
Topics: Alkaline Phosphatase; Amino Acids; Animals; Biomarkers; Calcium; Male; Mice; Mice, Inbred C57BL; Osteocalcin; Osteolysis; Osteoprotegerin; Phosphates; Polyethylene; Postoperative Period; Preoperative Period; RANK Ligand; Time Factors; X-Ray Microtomography | 2010 |
Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing.
Topics: Acid Phosphatase; Aging; Amino Acids; Animals; Biomechanical Phenomena; Bone Remodeling; Bony Callus; Disease Models, Animal; Female; Fracture Healing; Isoenzymes; Male; Mice; Mice, Mutant Strains; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis; Osteoprotegerin; Sex Characteristics; Tartrate-Resistant Acid Phosphatase | 2012 |
Relationships between age-related biochemical markers of bone turnover and OPG, TGF-β1 and TGF-β2 in native Chinese women.
Topics: Adult; Aged; Aging; Alkaline Phosphatase; Amino Acids; Asian People; Biomarkers; Bone and Bones; Collagen Type I; Cross-Sectional Studies; Female; Humans; Menopause; Middle Aged; Osteocalcin; Osteoprotegerin; Peptides; Phosphopeptides; Procollagen; Transforming Growth Factor beta1; Transforming Growth Factor beta2 | 2014 |
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Topics: Adaptor Proteins, Signal Transducing; Amino Acids; Animals; beta Catenin; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cell Lineage; Femur; Glycoproteins; Intercellular Signaling Peptides and Proteins; LDL-Receptor Related Proteins; Mice, Knockout; Muscles; Organ Specificity; Osteoblasts; Osteocalcin; Osteoclasts; Osteogenesis; Osteoprotegerin; RANK Ligand; Receptors, LDL; Stromal Cells; Wnt Signaling Pathway; X-Ray Microtomography | 2015 |
SERUM LEVELS OF FIBROBLAST GROWTH FACTOR-23, OSTEOPROTEGERIN, AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND IN PATIENTS WITH PROLACTINOMA.
Topics: Adult; Amino Acids; Antineoplastic Agents; Biomarkers, Tumor; Bone Density; Cabergoline; Cross-Sectional Studies; Ergolines; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Middle Aged; Osteocalcin; Osteoprotegerin; Pituitary Neoplasms; Prolactinoma; Prospective Studies; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Vitamin D | 2017 |